Myelodysplastische Syndrome View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-02-19

AUTHORS

C. Rautenberg, M. Kondakci, A. Nusch, J. Kaivers, K. Götze, R. Haas, T. Schroeder, U. Germing

ABSTRACT

Myelodysplastic syndromes (MDS) are clonal diseases of hematopoietic stem cells (HSC). They are typically associated with symptoms of dysplasia as well as chromosomal and/or molecular alterations, and characterized by hypercellular bone marrow with low peripheral blood cell counts. The recommended diagnostic workup thus includes cytomorphologic analysis of peripheral blood and bone marrow as well as cytogenetic banding techniques and, if necessary, molecular genetic analysis of bone marrow cells. The generated findings are not only important for classification of MDS according to World Health Organization (WHO) criteria, but also essential for prognostic estimation and treatment planning. Depending on the risk profile, which is classified according to the International Prognostic Scoring System—Revised Version (IPSS-R), and patient-specific factors, e.g., age and comorbidities, treatment can vary from supportive therapy such as blood transfusions and iron chelation in low-risk patients to allogeneic HSC transplantation with curative intent in high-risk patients with good general health and without comorbidities. More... »

PAGES

112-121

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11654-021-00291-2

DOI

http://dx.doi.org/10.1007/s11654-021-00291-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1135465254


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rautenberg", 
        "givenName": "C.", 
        "id": "sg:person.014702750321.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014702750321.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Onkologie und H\u00e4matologie, St. Lukas Klinik, Solingen, Deutschland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Onkologie und H\u00e4matologie, St. Lukas Klinik, Solingen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondakci", 
        "givenName": "M.", 
        "id": "sg:person.01150516001.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Praxis f\u00fcr Onkologie und H\u00e4matologie, Ratingen, Deutschland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Praxis f\u00fcr Onkologie und H\u00e4matologie, Ratingen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nusch", 
        "givenName": "A.", 
        "id": "sg:person.0577665631.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577665631.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaivers", 
        "givenName": "J.", 
        "id": "sg:person.011353714763.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011353714763.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie und Onkologie, TU M\u00fcnchen, M\u00fcnchen, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.6936.a", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie und Onkologie, TU M\u00fcnchen, M\u00fcnchen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "G\u00f6tze", 
        "givenName": "K.", 
        "id": "sg:person.01320201641.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320201641.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "R.", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schroeder", 
        "givenName": "T.", 
        "id": "sg:person.01271136615.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universit\u00e4t, Moorenstr.\u00a05, 40225, D\u00fcsseldorf, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germing", 
        "givenName": "U.", 
        "id": "sg:person.01362464041.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00277-020-04325-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132411275", 
          "https://doi.org/10.1007/s00277-020-04325-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41375-020-0917-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1128827022", 
          "https://doi.org/10.1038/s41375-020-0917-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2405030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041608232", 
          "https://doi.org/10.1038/sj.leu.2405030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41408-019-0248-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1122507687", 
          "https://doi.org/10.1038/s41408-019-0248-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403963", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000607804", 
          "https://doi.org/10.1038/sj.leu.2403963"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-02-19", 
    "datePublishedReg": "2021-02-19", 
    "description": "Myelodysplastic syndromes (MDS) are clonal diseases of hematopoietic stem cells (HSC). They are typically associated with symptoms of dysplasia as well as chromosomal and/or molecular alterations, and characterized by hypercellular bone marrow with low peripheral blood cell counts. The recommended diagnostic workup thus includes cytomorphologic analysis of peripheral blood and bone marrow as well as cytogenetic banding techniques and, if necessary, molecular genetic analysis of bone marrow cells. The generated findings are not only important for classification of MDS according to World Health Organization (WHO) criteria, but also essential for prognostic estimation and treatment planning. Depending on the risk profile, which is classified according to the International Prognostic Scoring System\u2014Revised Version (IPSS-R), and patient-specific factors, e.g., age and comorbidities, treatment can vary from supportive therapy such as blood transfusions and iron chelation in low-risk patients to allogeneic HSC transplantation with curative intent in high-risk patients with good general health and without comorbidities.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11654-021-00291-2", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1045320", 
        "issn": [
          "0946-4565", 
          "1862-8559"
        ], 
        "name": "best practice onkologie", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "keywords": [
      "myelodysplastic syndrome", 
      "bone marrow", 
      "hematopoietic stem cells", 
      "peripheral blood cell counts", 
      "International Prognostic Scoring System", 
      "World Health Organization criteria", 
      "classification of MDS", 
      "low-risk patients", 
      "high-risk patients", 
      "prognostic scoring system", 
      "good general health", 
      "hypercellular bone marrow", 
      "blood cell count", 
      "patient-specific factors", 
      "bone marrow cells", 
      "curative intent", 
      "blood transfusion", 
      "supportive therapy", 
      "peripheral blood", 
      "Organization criteria", 
      "diagnostic workup", 
      "general health", 
      "clonal disease", 
      "molecular alterations", 
      "cell count", 
      "cytomorphologic analysis", 
      "scoring system", 
      "HSC transplantation", 
      "risk profile", 
      "marrow cells", 
      "iron chelation", 
      "prognostic estimation", 
      "treatment planning", 
      "comorbidities", 
      "patients", 
      "syndrome", 
      "marrow", 
      "stem cells", 
      "molecular genetic analysis", 
      "transfusion", 
      "cells", 
      "transplantation", 
      "dysplasia", 
      "therapy", 
      "symptoms", 
      "workup", 
      "cytogenetic banding techniques", 
      "disease", 
      "blood", 
      "age", 
      "treatment", 
      "banding techniques", 
      "alterations", 
      "health", 
      "count", 
      "genetic analysis", 
      "findings", 
      "factors", 
      "criteria", 
      "intent", 
      "analysis", 
      "chelation", 
      "profile", 
      "classification", 
      "planning", 
      "technique", 
      "version", 
      "system", 
      "estimation"
    ], 
    "name": "Myelodysplastische Syndrome", 
    "pagination": "112-121", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1135465254"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11654-021-00291-2"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11654-021-00291-2", 
      "https://app.dimensions.ai/details/publication/pub.1135465254"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_909.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11654-021-00291-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11654-021-00291-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11654-021-00291-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11654-021-00291-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11654-021-00291-2'


 

This table displays all metadata directly associated to this object as RDF triples.

203 TRIPLES      21 PREDICATES      98 URIs      85 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11654-021-00291-2 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nfe22b6eeb1ff4ff986ff7d693487c1a7
4 schema:citation sg:pub.10.1007/s00277-020-04325-7
5 sg:pub.10.1038/s41375-020-0917-7
6 sg:pub.10.1038/s41408-019-0248-y
7 sg:pub.10.1038/sj.leu.2403963
8 sg:pub.10.1038/sj.leu.2405030
9 schema:datePublished 2021-02-19
10 schema:datePublishedReg 2021-02-19
11 schema:description Myelodysplastic syndromes (MDS) are clonal diseases of hematopoietic stem cells (HSC). They are typically associated with symptoms of dysplasia as well as chromosomal and/or molecular alterations, and characterized by hypercellular bone marrow with low peripheral blood cell counts. The recommended diagnostic workup thus includes cytomorphologic analysis of peripheral blood and bone marrow as well as cytogenetic banding techniques and, if necessary, molecular genetic analysis of bone marrow cells. The generated findings are not only important for classification of MDS according to World Health Organization (WHO) criteria, but also essential for prognostic estimation and treatment planning. Depending on the risk profile, which is classified according to the International Prognostic Scoring System—Revised Version (IPSS-R), and patient-specific factors, e.g., age and comorbidities, treatment can vary from supportive therapy such as blood transfusions and iron chelation in low-risk patients to allogeneic HSC transplantation with curative intent in high-risk patients with good general health and without comorbidities.
12 schema:genre article
13 schema:isAccessibleForFree false
14 schema:isPartOf N65543402e8154b788da19141857755d7
15 N70137efc43204f4499134c15a55d59a7
16 sg:journal.1045320
17 schema:keywords HSC transplantation
18 International Prognostic Scoring System
19 Organization criteria
20 World Health Organization criteria
21 age
22 alterations
23 analysis
24 banding techniques
25 blood
26 blood cell count
27 blood transfusion
28 bone marrow
29 bone marrow cells
30 cell count
31 cells
32 chelation
33 classification
34 classification of MDS
35 clonal disease
36 comorbidities
37 count
38 criteria
39 curative intent
40 cytogenetic banding techniques
41 cytomorphologic analysis
42 diagnostic workup
43 disease
44 dysplasia
45 estimation
46 factors
47 findings
48 general health
49 genetic analysis
50 good general health
51 health
52 hematopoietic stem cells
53 high-risk patients
54 hypercellular bone marrow
55 intent
56 iron chelation
57 low-risk patients
58 marrow
59 marrow cells
60 molecular alterations
61 molecular genetic analysis
62 myelodysplastic syndrome
63 patient-specific factors
64 patients
65 peripheral blood
66 peripheral blood cell counts
67 planning
68 profile
69 prognostic estimation
70 prognostic scoring system
71 risk profile
72 scoring system
73 stem cells
74 supportive therapy
75 symptoms
76 syndrome
77 system
78 technique
79 therapy
80 transfusion
81 transplantation
82 treatment
83 treatment planning
84 version
85 workup
86 schema:name Myelodysplastische Syndrome
87 schema:pagination 112-121
88 schema:productId N03ebf7881ba94eb29b4575a65afb19d3
89 Nb2332cab09b743e1b43f84d4bd6e99a2
90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1135465254
91 https://doi.org/10.1007/s11654-021-00291-2
92 schema:sdDatePublished 2022-08-04T17:12
93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
94 schema:sdPublisher N4eceeab0b2ba4beaba46e7f74d1b71f9
95 schema:url https://doi.org/10.1007/s11654-021-00291-2
96 sgo:license sg:explorer/license/
97 sgo:sdDataset articles
98 rdf:type schema:ScholarlyArticle
99 N03ebf7881ba94eb29b4575a65afb19d3 schema:name dimensions_id
100 schema:value pub.1135465254
101 rdf:type schema:PropertyValue
102 N150aa9842fd94ea8b78ef5e7148e29c9 rdf:first sg:person.0577665631.76
103 rdf:rest Nee69632f7ba247e58b128cd3b83e857b
104 N151d02d57ff14a79b31b1966bfb99035 rdf:first sg:person.01362464041.20
105 rdf:rest rdf:nil
106 N241a3ca8fd0e4794a9aeefcde783d4c4 rdf:first sg:person.01271136615.68
107 rdf:rest N151d02d57ff14a79b31b1966bfb99035
108 N4eceeab0b2ba4beaba46e7f74d1b71f9 schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N65543402e8154b788da19141857755d7 schema:issueNumber 3
111 rdf:type schema:PublicationIssue
112 N70137efc43204f4499134c15a55d59a7 schema:volumeNumber 16
113 rdf:type schema:PublicationVolume
114 N7facb8a29e4749618f664e78674dc279 rdf:first sg:person.01127414674.14
115 rdf:rest N241a3ca8fd0e4794a9aeefcde783d4c4
116 N96fd1cb1d4c24a5bb0fcb4e1550c56a8 rdf:first sg:person.01320201641.22
117 rdf:rest N7facb8a29e4749618f664e78674dc279
118 Nb2332cab09b743e1b43f84d4bd6e99a2 schema:name doi
119 schema:value 10.1007/s11654-021-00291-2
120 rdf:type schema:PropertyValue
121 Ndc98f7f311a54143a43510e86aca1708 rdf:first sg:person.01150516001.45
122 rdf:rest N150aa9842fd94ea8b78ef5e7148e29c9
123 Nee69632f7ba247e58b128cd3b83e857b rdf:first sg:person.011353714763.51
124 rdf:rest N96fd1cb1d4c24a5bb0fcb4e1550c56a8
125 Nfe22b6eeb1ff4ff986ff7d693487c1a7 rdf:first sg:person.014702750321.08
126 rdf:rest Ndc98f7f311a54143a43510e86aca1708
127 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
128 schema:name Medical and Health Sciences
129 rdf:type schema:DefinedTerm
130 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
131 schema:name Cardiorespiratory Medicine and Haematology
132 rdf:type schema:DefinedTerm
133 sg:journal.1045320 schema:issn 0946-4565
134 1862-8559
135 schema:name best practice onkologie
136 schema:publisher Springer Nature
137 rdf:type schema:Periodical
138 sg:person.01127414674.14 schema:affiliation grid-institutes:grid.411327.2
139 schema:familyName Haas
140 schema:givenName R.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
142 rdf:type schema:Person
143 sg:person.011353714763.51 schema:affiliation grid-institutes:grid.411327.2
144 schema:familyName Kaivers
145 schema:givenName J.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011353714763.51
147 rdf:type schema:Person
148 sg:person.01150516001.45 schema:affiliation grid-institutes:None
149 schema:familyName Kondakci
150 schema:givenName M.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45
152 rdf:type schema:Person
153 sg:person.01271136615.68 schema:affiliation grid-institutes:grid.411327.2
154 schema:familyName Schroeder
155 schema:givenName T.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68
157 rdf:type schema:Person
158 sg:person.01320201641.22 schema:affiliation grid-institutes:grid.6936.a
159 schema:familyName Götze
160 schema:givenName K.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320201641.22
162 rdf:type schema:Person
163 sg:person.01362464041.20 schema:affiliation grid-institutes:grid.411327.2
164 schema:familyName Germing
165 schema:givenName U.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20
167 rdf:type schema:Person
168 sg:person.014702750321.08 schema:affiliation grid-institutes:grid.411327.2
169 schema:familyName Rautenberg
170 schema:givenName C.
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014702750321.08
172 rdf:type schema:Person
173 sg:person.0577665631.76 schema:affiliation grid-institutes:None
174 schema:familyName Nusch
175 schema:givenName A.
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577665631.76
177 rdf:type schema:Person
178 sg:pub.10.1007/s00277-020-04325-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132411275
179 https://doi.org/10.1007/s00277-020-04325-7
180 rdf:type schema:CreativeWork
181 sg:pub.10.1038/s41375-020-0917-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128827022
182 https://doi.org/10.1038/s41375-020-0917-7
183 rdf:type schema:CreativeWork
184 sg:pub.10.1038/s41408-019-0248-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1122507687
185 https://doi.org/10.1038/s41408-019-0248-y
186 rdf:type schema:CreativeWork
187 sg:pub.10.1038/sj.leu.2403963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000607804
188 https://doi.org/10.1038/sj.leu.2403963
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/sj.leu.2405030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041608232
191 https://doi.org/10.1038/sj.leu.2405030
192 rdf:type schema:CreativeWork
193 grid-institutes:None schema:alternateName Onkologie und Hämatologie, St. Lukas Klinik, Solingen, Deutschland
194 Praxis für Onkologie und Hämatologie, Ratingen, Deutschland
195 schema:name Onkologie und Hämatologie, St. Lukas Klinik, Solingen, Deutschland
196 Praxis für Onkologie und Hämatologie, Ratingen, Deutschland
197 rdf:type schema:Organization
198 grid-institutes:grid.411327.2 schema:alternateName Klinik für Hämatologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland
199 schema:name Klinik für Hämatologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland
200 rdf:type schema:Organization
201 grid-institutes:grid.6936.a schema:alternateName Klinik für Hämatologie und Onkologie, TU München, München, Deutschland
202 schema:name Klinik für Hämatologie und Onkologie, TU München, München, Deutschland
203 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...